BIOMAT Database Logo BIOMAT Database Logo

Pyridoxine-dependent epilepsy due to antiquitin deficiency: achieving a favourable outcome. 2013

Renata Oliveira, and Cristina Pereira, and Fidjy Rodrigues, and Claudia Alfaite, and Paula Garcia, and Conceição Robalo, and Isabel Fineza, and Olavo Gonçalves, and Eduard Struys, and Gajja Salomons, and Cornelis Jakobs, and Luísa Diogo
Serviço de Genética Médica.

We report 4 pyridoxine-dependent epilepsy patients in which good outcome was determined in three. The 4 patients were male and aged from 7 to 24 years old (from three unrelated Caucasian families). A clinical diagnosis of neonatal pyridoxine-dependent epilepsy was confirmed by biochemical and genetic studies. Clinical evaluation was performed and medical records were reviewed for therapy implementation and management, neurodevelopment outcome, magnetic resonance imaging, and electroencephalography. All were taking pyridoxine treatment and were seizure-free. Elevated urinary alpha-aminoadipic semialdehyde excretion was found in all patients. Antiquitin gene analysis identified a large homozygous deletion in one patient and two heterozygous mutations in the others. Treatment with pyridoxine should be attempted for all cases of infantile and childhood refractory epilepsy, as has been the case over the last 20 years. Currently, urinary alpha-aminoadipic semialdehyde is a reliable biomarker of pyridoxine-dependent epilepsy, even under pyridoxine treatment. Detection of mutations in the antiquitin gene, encoding alpha-aminoadipic semialdehyde dehydrogenase, establishes the diagnosis and allows for adequate genetic counselling.

UI MeSH Term Description Entries
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011736 Pyridoxine The 4-methanol form of VITAMIN B 6 which is converted to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. Although pyridoxine and Vitamin B 6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading (EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990). Pyridoxin,Pyridoxine Hydrochloride,Pyridoxol,Pyridoxol Hydrochloride,Rodex
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000444 Aldehyde Dehydrogenase An enzyme that oxidizes an aldehyde in the presence of NAD+ and water to an acid and NADH. This enzyme was formerly classified as EC 1.1.1.70. D-Glucuronolactone Dehydrogenase,Aldehyde Dehydrogenase (NAD(+)),Aldehyde Dehydrogenase E1,Aldehyde Dehydrogenase E2,Aldehyde-NAD Oxidoreductase,Aldehyde NAD Oxidoreductase,D Glucuronolactone Dehydrogenase,Dehydrogenase, Aldehyde,Dehydrogenase, D-Glucuronolactone
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Renata Oliveira, and Cristina Pereira, and Fidjy Rodrigues, and Claudia Alfaite, and Paula Garcia, and Conceição Robalo, and Isabel Fineza, and Olavo Gonçalves, and Eduard Struys, and Gajja Salomons, and Cornelis Jakobs, and Luísa Diogo
A novel mouse model for pyridoxine-dependent epilepsy due to antiquitin deficiency.
November 2020, Human molecular genetics,
Renata Oliveira, and Cristina Pereira, and Fidjy Rodrigues, and Claudia Alfaite, and Paula Garcia, and Conceição Robalo, and Isabel Fineza, and Olavo Gonçalves, and Eduard Struys, and Gajja Salomons, and Cornelis Jakobs, and Luísa Diogo
Pyridoxine-dependent epilepsy owing to antiquitin deficiency--mutation in the ALDH7A1 gene.
May 2013, Paediatrics and international child health,
Renata Oliveira, and Cristina Pereira, and Fidjy Rodrigues, and Claudia Alfaite, and Paula Garcia, and Conceição Robalo, and Isabel Fineza, and Olavo Gonçalves, and Eduard Struys, and Gajja Salomons, and Cornelis Jakobs, and Luísa Diogo
New insights into human lysine degradation pathways with relevance to pyridoxine-dependent epilepsy due to antiquitin deficiency.
July 2019, Journal of inherited metabolic disease,
Renata Oliveira, and Cristina Pereira, and Fidjy Rodrigues, and Claudia Alfaite, and Paula Garcia, and Conceição Robalo, and Isabel Fineza, and Olavo Gonçalves, and Eduard Struys, and Gajja Salomons, and Cornelis Jakobs, and Luísa Diogo
Pyridoxine-Dependent Epilepsy and Antiquitin Deficiency Resulting in Neonatal-Onset Refractory Seizures.
December 2021, Brain sciences,
Renata Oliveira, and Cristina Pereira, and Fidjy Rodrigues, and Claudia Alfaite, and Paula Garcia, and Conceição Robalo, and Isabel Fineza, and Olavo Gonçalves, and Eduard Struys, and Gajja Salomons, and Cornelis Jakobs, and Luísa Diogo
Beneficial outcome of early dietary lysine restriction as an adjunct to pyridoxine therapy in a child with pyridoxine dependant epilepsy due to Antiquitin deficiency.
July 2020, JIMD reports,
Renata Oliveira, and Cristina Pereira, and Fidjy Rodrigues, and Claudia Alfaite, and Paula Garcia, and Conceição Robalo, and Isabel Fineza, and Olavo Gonçalves, and Eduard Struys, and Gajja Salomons, and Cornelis Jakobs, and Luísa Diogo
Glial localization of antiquitin: implications for pyridoxine-dependent epilepsy.
January 2014, Annals of neurology,
Renata Oliveira, and Cristina Pereira, and Fidjy Rodrigues, and Claudia Alfaite, and Paula Garcia, and Conceição Robalo, and Isabel Fineza, and Olavo Gonçalves, and Eduard Struys, and Gajja Salomons, and Cornelis Jakobs, and Luísa Diogo
Metabolomics analysis of antiquitin deficiency in cultured human cells and plasma: Relevance to pyridoxine-dependent epilepsy.
January 2023, Journal of inherited metabolic disease,
Renata Oliveira, and Cristina Pereira, and Fidjy Rodrigues, and Claudia Alfaite, and Paula Garcia, and Conceição Robalo, and Isabel Fineza, and Olavo Gonçalves, and Eduard Struys, and Gajja Salomons, and Cornelis Jakobs, and Luísa Diogo
[Pyridoxine-dependent epilepsy due to deficiency in the PNPO gene].
October 2019, Revista de neurologia,
Renata Oliveira, and Cristina Pereira, and Fidjy Rodrigues, and Claudia Alfaite, and Paula Garcia, and Conceição Robalo, and Isabel Fineza, and Olavo Gonçalves, and Eduard Struys, and Gajja Salomons, and Cornelis Jakobs, and Luísa Diogo
Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up.
January 2011, Molecular genetics and metabolism,
Renata Oliveira, and Cristina Pereira, and Fidjy Rodrigues, and Claudia Alfaite, and Paula Garcia, and Conceição Robalo, and Isabel Fineza, and Olavo Gonçalves, and Eduard Struys, and Gajja Salomons, and Cornelis Jakobs, and Luísa Diogo
Atypical pyridoxine-dependent epilepsy due to a pseudoexon in ALDH7A1.
April 2012, Molecular genetics and metabolism,
Copied contents to your clipboard!